CHINA PHARMA HOLDINGS, INC. Financial Ratios
CPHI|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-14.0%
Profit Margin
-76.9%
Net Income / Revenue
Asset Turnover
0.13
Revenue / Total Assets
Equity Multiplier
1.36
Total Assets / Equity
Composite: -14.0% (reported: -14.0%)
Profitability
Liquidity
Current Ratio
0.32
Quick Ratio
0.10
Solvency
Interest Coverage
5.44
Efficiency
Asset Turnover
0.13
Inventory Turnover
2.64
Days Sales Outstanding
21 days
As of FY2025 · SEC 10-K · Updated Jun 24, 2026
Earnings Quality
Accrual Ratio
-14.5%
+1.4pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.